Address
Email addresses
Phone numbers
Rödl & Partner on üks juhtivaid rahvusvahelisi professionaalseid raamatupidamis-, auditi-, õigus-, maksu- ja finantsteenuseid pakkuv ettevõte Eestis.
Name
MIP Pharma OÜ
Registry code
11938815
VAT number
EE101378589
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
10.05.2010 (14)
Financial year
01.07-30.06
Capital
2 606.00 €
Activity
46181 - Agents specialised in the sale of other particular products
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
RÖDL & PARTNER OÜ 10219320 | - | Contact person | - |
2019 12.11.2020 | 2020 01.09.2021 | 2021 14.09.2022 | 2022 29.12.2023 | |
---|---|---|---|---|
Total Revenue | 80 193 € | 81 296 € | 39 101 € | 15 112 € |
Net profit (loss) for the period | -4 588 € | -32 908 € | 32 641 € | 9 133 € |
Profit Margin | -6% | -40% | 83% | 60% |
Current Assets | 22 580 € | 31 902 € | 45 375 € | 54 848 € |
Fixed Assets | 19 518 € | 0 € | - | - |
Total Assets | 42 098 € | 31 902 € | 45 375 € | 54 848 € |
Current Liabilities | 47 457 € | 45 179 € | 1 011 € | 1 351 € |
Non Current Liabilities | - | - | - | - |
Total Liabilities | - | - | - | - |
Share Capital | - | - | - | - |
Equity | -5 359 € | -13 277 € | 44 364 € | 53 497 € |
Employees | 2 | 2 | 0 | 0 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | 23 068.44 € | - | - | - |
2023 Q4 | 11 922.02 € | - | - | - |
2023 Q3 | 4 714.62 € | 2 € | - | - |
2023 Q2 | 2 849.72 € | - | - | - |
2023 Q1 | 4 573.62 € | - | - | - |
2022 Q4 | 3 213.86 € | - | - | - |
2022 Q3 | 12 778.41 € | 11.25 € | - | - |
2022 Q2 | 9 161.82 € | 28.75 € | - | - |
2022 Q1 | 7 672.44 € | - | - | - |
2021 Q4 | 6 753.36 € | - | - | - |
2021 Q3 | 8 777.01 € | 167.51 € | 104.3 € | - |
2021 Q2 | 23 243.23 € | 17 705.15 € | 16 667.53 € | - |
2021 Q1 | 10 031.84 € | 8 501.37 € | 8 984.94 € | 2 |
2020 Q4 | 20 899.96 € | 8 377.8 € | 8 850.97 € | 2 |
2020 Q3 | 62 577.47 € | 8 501.37 € | 8 984.94 € | 2 |
2020 Q2 | 11 773.43 € | 8 501.37 € | 8 984.94 € | 2 |
2020 Q1 | 18 565.3 € | 7 652.64 € | 8 064.77 € | 2 |